TU3-28333-53452
4 vaccinations
4 coded responses
37 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
F47-31773-28717
Child or adolescent in my care · Female · 2022-06-22
Q3X-29176-14879
Child or adolescent in my care · Male · 2022-06-22
3QM-17706-31216
Child or adolescent in my care · Female · 2022-06-22
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
- 2021-01-07
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Fair · Joint pains · Be unable to do your normal daily activitiesFree text: Tail boneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-02-03
Dose 2 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-06
- 2021-03-12
- 2021-03-17
- 2021-05-05
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-09
-
2021-08-09
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-22
Dose 3 — Moderna
- 2021-10-25
-
2022-09-13
Dose 4 — Moderna
- 2022-09-13
- 2022-09-16
- 2022-09-17
- 2022-09-22
- 2022-09-27
- 2022-10-05
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-12-13
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-16
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-03 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-09-13 | Moderna | No |
Call center
3 call center cases
1 successful · 1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Tail bone
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Vertigo
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release